Target intelligence / Profile preview

G antigen 12C (GAGE12C)

Target
GAGE12C
Molecular classification
Cancer/testis antigen, Protein (GAGE family), Other
01

Overview

G antigen 12C (GAGE12C) is a member of the GAGE gene family, a group of cancer/testis antigens located on the X chromosome and expressed in various tumors but not in most normal tissues except for testis and occasionally placenta[7]. These proteins are characterized structurally by the GAGE domain and are believed to participate in protein-protein interactions, although their precise physiological function remains poorly defined[1][7]. GAGE family members, including GAGE12C, are commonly used in cancer immunology as diagnostic markers and potential immunotherapy targets because of their expression pattern in cancer[7]. GAGE12C is a protein-coding gene with protein binding activity and is considered a tumor biomarker, particularly relevant for cancers where GAGE expression is elevated[7]. GAGE12C is not a receptor, enzyme, or transporter, but falls under the "Other" category, specifically as a cancer/testis antigen often considered for therapeutic targeting or as a biomarker in oncology[7]. No small-molecule or biological drugs are currently known to specifically target GAGE12C based on the available data. If further details on cancer types, clinical use, or functional studies are required, consult specialized oncology and immunotherapy databases due to rapid developments in this area.

Other names
G antigen 12B/C/D/EGAGE12BGAGE-12BGAGE-12CGAGE-12DGAGE-12EOTTHUMG00000024144g antigen 12C/D/E
02

Biological functions

Protein bindingUnknown physiological function (as is typical for GAGE proteins)
03

Disease associations

Cancer (widely expressed in various cancers)
04

Safety considerations

Off-tumor/on-target expression risk (as a cancer/testis antigen, aberrant expression could present safety concerns with immunotherapy approaches, but no specific challenges were listed in the search results)
05

Biomarkers

Tumor biomarker (used in cancer research and patient stratification)

Beyond the preview

Go deeper on G antigen 12C (GAGE12C).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on G antigen 12C (GAGE12C).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call